Posted by Michael Wonder on 31 Jan 2021
Greater access to life-changing medicine for Australians with ADHD
30 January 2021 - On 1 February, the Government is expanding the listing of Vyvanse (lisdexamphetamine) to include patients who are diagnosed with ADHD after they turn 18 years old.
The PBS listing extension means Vyvanse is now subsidised for Australians diagnosed as adults, rather than as children.
